Your browser doesn't support javascript.
loading
Diagnosis and classification of optic neuritis.
Petzold, Axel; Fraser, Clare L; Abegg, Mathias; Alroughani, Raed; Alshowaeir, Daniah; Alvarenga, Regina; Andris, Cécile; Asgari, Nasrin; Barnett, Yael; Battistella, Roberto; Behbehani, Raed; Berger, Thomas; Bikbov, Mukharram M; Biotti, Damien; Biousse, Valerie; Boschi, Antonella; Brazdil, Milan; Brezhnev, Andrei; Calabresi, Peter A; Cordonnier, Monique; Costello, Fiona; Cruz, Franz M; Cunha, Leonardo Provetti; Daoudi, Smail; Deschamps, Romain; de Seze, Jerome; Diem, Ricarda; Etemadifar, Masoud; Flores-Rivera, Jose; Fonseca, Pedro; Frederiksen, Jette; Frohman, Elliot; Frohman, Teresa; Tilikete, Caroline Froment; Fujihara, Kazuo; Gálvez, Alberto; Gouider, Riadh; Gracia, Fernando; Grigoriadis, Nikolaos; Guajardo, José M; Habek, Mario; Hawlina, Marko; Martínez-Lapiscina, Elena H; Hooker, Juzar; Hor, Jyh Yung; Howlett, William; Huang-Link, Yumin; Idrissova, Zhannat; Illes, Zsolt; Jancic, Jasna.
Afiliação
  • Petzold A; The National Hospital for Neurology and Neurosurgery, University College London, London, UK; Moorfields Eye Hospital, London, UK; Neuro-ophthalmology Expert Centre, Amsterdam University Medical Center, Amsterdam, Netherlands. Electronic address: a.petzold@ucl.ac.uk.
  • Fraser CL; Department of Ophthalmology, University of Sydney, Sydney, NSW, Australia.
  • Abegg M; Department of Ophthalmology, University of Bern, Bern, Switzerland.
  • Alroughani R; Division of Neurology, Department of Medicine, Al-Amiri Hospital, Kuwait City, Kuwait.
  • Alshowaeir D; Department of Ophthalmology, King Saud University, Riyadh, Saudi Arabia.
  • Alvarenga R; Department of Neurology, Universidade Federal do Estado do Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
  • Andris C; Department of Ophthalmology, University Hospital Liege, University of Liège, Liège, Belgium.
  • Asgari N; Department of Neurology, Slagelse and Institute of Regional Health Research, and Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
  • Barnett Y; Department of Neuroradiology, St Vincent's Hospital, Sydney, NSW, Australia.
  • Battistella R; Department of Neuro-Ophthalmology, University of São Paulo, São Paulo, Brazil.
  • Behbehani R; Neuro-Ophthalmology Unit, Ibn Sina Hospital, Kuwait City, Kuwait.
  • Berger T; Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Bikbov MM; Ufa Eye Research Institute, Ufa, Russia.
  • Biotti D; Unité de Neurologie Inflammatoire B4, CHU Pierre-Paul Riquet/Purpan, Toulouse, France.
  • Biousse V; Neuro-Ophthalmology Unit, Emory Eye Center, Emory University, Atlanta, GA, USA.
  • Boschi A; Department of Head and Neck, Université Catholique de Louvain, Brussels, Belgium; Department of Ophthalmology, Cliniques Universitaires Saint Luc, Brusseles, Belgium.
  • Brazdil M; Department of Neurology, Masaryk University, Brno, Czech Republic; St Anne's University Hospital, Brno, Czech Republic.
  • Brezhnev A; Department of Ophthalmology, Kursk State Medical University, Kursk, Russia.
  • Calabresi PA; The Solomon H Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Cordonnier M; Department of Ophthalmology, Université Libre de Bruxelles, Bruxelles, Belgium.
  • Costello F; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.
  • Cruz FM; College of Medicine, University of the Philippines-Philippine General Hospital, Manila, Philippines.
  • Cunha LP; Surgery Department of Juiz de Fora Medical School, Federal University of Juiz de Fora, Juiz de Fora, Brazil.
  • Daoudi S; Department of Neurology, University Mouloud Mammeri de Ttizi Ouzou, Ttizi Ouzou, Algeria.
  • Deschamps R; Department of Neurology, Hospital Foundation Adolphe de Rothschild, Paris, France.
  • de Seze J; Department of Neurology, Hopitaux Universitaires Strasbourg, Strasbourg, France.
  • Diem R; Department of Neurology, University Clinic Heidelberg, Heidelberg, Germany.
  • Etemadifar M; Department of Neurosurgery, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Flores-Rivera J; Universidad Nacional Autónoma de México, Instituto Nacional de Neurología y Neurocirugía, Centro Médico ABC, Mexico City, Mexico.
  • Fonseca P; Department of Ophthalmology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; Coimbra Institute for Biomedical Imaging and Translational Research (CIBIT), University of Coimbra, Coimbra, Portugal.
  • Frederiksen J; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Department of Neurology, Copenhagen University Hospital, Copenhagen, Denmark.
  • Frohman E; Department of Neurology, Laboratory of Neuroimmunology, Stanford University School of Medicine, Palo Alto, CA, USA.
  • Frohman T; Department of Neurology, Laboratory of Neuroimmunology, Stanford University School of Medicine, Palo Alto, CA, USA.
  • Tilikete CF; Lyon Neurosciences Research Center, Lyon I University, Lyon France; Neuro-Ophthalmology Unit, Hospices Civils de Lyon, Lyon, France.
  • Fujihara K; Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, Koriyama, Japan.
  • Gálvez A; Department of Ophthalmology, University of Alberta, AB, Canada.
  • Gouider R; Department of Neurology, Razi University Hospital, University of Tunis El Manar, Tunis, Tunisia.
  • Gracia F; Department of Neurology, Hospital Santo Tomás, Panama City, Panama; Instituto Conmemorativo Gorgas de Estudios de la Salud, Universidad Interamericana de Panama, Panama City, Panama.
  • Grigoriadis N; Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Guajardo JM; Servicio de Oftalmología, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, Chile.
  • Habek M; Department of Neurology, University of Zagreb School of Medicine, Zagreb, Croatia; Department of Neurology, University Hospital Center Zagreb, Zagreb, Croatia.
  • Hawlina M; Eye Hospital, University Medical Centre, Ljubljana, Slovenia.
  • Martínez-Lapiscina EH; Department of Neurology, Hospital Clinic of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Hooker J; Aga Khan University Hospital, Nairobi, Kenya.
  • Hor JY; Department of Neurology, Penang General Hospital, Penang, Malaysia.
  • Howlett W; Department of Neurology, Kilimanjaro Christian Medical Center (KCMC), Moshi, Tanzania.
  • Huang-Link Y; Department of Neurology, Linköping University Hospital, Linköping, Sweden.
  • Idrissova Z; Department of Neurology, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
  • Illes Z; Department of Neurology, Odense University Hospital, Odense, Denmark.
  • Jancic J; Clinic of Neurology and Psychiatry for Children and Youth, Faculty of Medicine University of Belgrade, Belgrade, Serbia.
Lancet Neurol ; 21(12): 1120-1134, 2022 12.
Article em En | MEDLINE | ID: mdl-36179757
ABSTRACT
There is no consensus regarding the classification of optic neuritis, and precise diagnostic criteria are not available. This reality means that the diagnosis of disorders that have optic neuritis as the first manifestation can be challenging. Accurate diagnosis of optic neuritis at presentation can facilitate the timely treatment of individuals with multiple sclerosis, neuromyelitis optica spectrum disorder, or myelin oligodendrocyte glycoprotein antibody-associated disease. Epidemiological data show that, cumulatively, optic neuritis is most frequently caused by many conditions other than multiple sclerosis. Worldwide, the cause and management of optic neuritis varies with geographical location, treatment availability, and ethnic background. We have developed diagnostic criteria for optic neuritis and a classification of optic neuritis subgroups. Our diagnostic criteria are based on clinical features that permit a diagnosis of possible optic neuritis; further paraclinical tests, utilising brain, orbital, and retinal imaging, together with antibody and other protein biomarker data, can lead to a diagnosis of definite optic neuritis. Paraclinical tests can also be applied retrospectively on stored samples and historical brain or retinal scans, which will be useful for future validation studies. Our criteria have the potential to reduce the risk of misdiagnosis, provide information on optic neuritis disease course that can guide future treatment trial design, and enable physicians to judge the likelihood of a need for long-term pharmacological management, which might differ according to optic neuritis subgroups.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neurite Óptica / Neuromielite Óptica / Esclerose Múltipla Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Lancet Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neurite Óptica / Neuromielite Óptica / Esclerose Múltipla Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Lancet Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2022 Tipo de documento: Article